We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out how the scheme works, including issuing shares and raising money, and how to submit your compliance statement.
View highlights of some of our most recently published research on this page. You can also download a complete list of our published research.
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
The review of the safety of isotretinoin has concluded.
Using an ecological momentary assessment to evaluate your digital health product.
Description of UKHSA adult surveillance programmes for COVID-19.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Find out how the scheme works, including issuing shares and raising money and how to submit a compliance statement.
Guidance for manufacturers, importers and distributors.
Information for patients, healthcare professionals and developers of new medicines
Form and guidance notes for immigration advice organisations to apply to increase their level of work.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Foresight project looking at the scientific and technological areas that could transform the UK economy in the future.
This document explains the Prostate Cancer Risk Management Programme (PCRMP), PSA testing and evidence against a national screening programme.
The Stimulating Physics Network provides free, bespoke support for teachers of physics to increase the take-up of A level physics, particularly by girls.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.